278 related articles for article (PubMed ID: 30634044)
1. First detection and characterization of macrolide-resistant Mycoplasma pneumoniae strains in Cuba.
Rodriguez N; Mondeja B; Sardiñas R; Vega D; Dumke R
Int J Infect Dis; 2019 Mar; 80():115-117. PubMed ID: 30634044
[TBL] [Abstract][Full Text] [Related]
2. Prevalence, genotyping and macrolide resistance of Mycoplasma pneumoniae among isolates of patients with respiratory tract infections, Central Slovenia, 2006 to 2014.
Kogoj R; Mrvic T; Praprotnik M; Kese D
Euro Surveill; 2015; 20(37):. PubMed ID: 26536357
[TBL] [Abstract][Full Text] [Related]
3. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
[TBL] [Abstract][Full Text] [Related]
4. Overview of antimicrobial options for Mycoplasma pneumoniae pneumonia: focus on macrolide resistance.
Cao B; Qu JX; Yin YD; Eldere JV
Clin Respir J; 2017 Jul; 11(4):419-429. PubMed ID: 26365811
[TBL] [Abstract][Full Text] [Related]
5. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
Lung DC; Chan YH; Kwong L; Que TL
Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.
Dumke R; von Baum H; Lück PC; Jacobs E
Clin Microbiol Infect; 2010 Jun; 16(6):613-6. PubMed ID: 19765022
[TBL] [Abstract][Full Text] [Related]
7. Increased macrolide resistance of Mycoplasma pneumoniae in France directly detected in clinical specimens by real-time PCR and melting curve analysis.
Peuchant O; Ménard A; Renaudin H; Morozumi M; Ubukata K; Bébéar CM; Pereyre S
J Antimicrob Chemother; 2009 Jul; 64(1):52-8. PubMed ID: 19429926
[TBL] [Abstract][Full Text] [Related]
8. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
9. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Lightmix Mycoplasma macrolide assay for detection of macrolide-resistant Mycoplasma pneumoniae in pneumonia patients.
Wagner K; Imkamp F; Pires VP; Keller PM
Clin Microbiol Infect; 2019 Mar; 25(3):383.e5-383.e7. PubMed ID: 30391582
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility and genotyping of
Zhao F; Liu J; Shi W; Huang F; Liu L; Zhao S; Zhang J
Antimicrob Resist Infect Control; 2019; 8():18. PubMed ID: 30697421
[TBL] [Abstract][Full Text] [Related]
12.
Dou HW; Tian XJ; Xin L; Wei R; Zhou W; Wang H; Qin XG; Shao JY; Xu BP; Ge LX; Shi DW
Biomed Environ Sci; 2020 Dec; 33(12):916-924. PubMed ID: 33472731
[TBL] [Abstract][Full Text] [Related]
13. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia.
Miyashita N; Kawai Y; Akaike H; Ouchi K; Hayashi T; Kurihara T; Okimoto N;
BMC Infect Dis; 2012 May; 12():126. PubMed ID: 22650321
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms of macrolide resistance in clinical isolates of Mycoplasma pneumoniae from China.
Xin D; Mi Z; Han X; Qin L; Li J; Wei T; Chen X; Ma S; Hou A; Li G; Shi D
Antimicrob Agents Chemother; 2009 May; 53(5):2158-9. PubMed ID: 19273685
[TBL] [Abstract][Full Text] [Related]
15. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumonia.
Morozumi M; Iwata S; Hasegawa K; Chiba N; Takayanagi R; Matsubara K; Nakayama E; Sunakawa K; Ubukata K;
Antimicrob Agents Chemother; 2008 Jan; 52(1):348-50. PubMed ID: 17954691
[TBL] [Abstract][Full Text] [Related]
16. Rapid detection of Mycoplasma pneumoniae and its macrolide-resistance mutation by Cycleave PCR.
Liu Y; Ye X; Zhang H; Wu Z; Xu X
Diagn Microbiol Infect Dis; 2014 Apr; 78(4):333-7. PubMed ID: 24503503
[TBL] [Abstract][Full Text] [Related]
17. Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing.
Spuesens EB; Hoogenboezem T; Sluijter M; Hartwig NG; van Rossum AM; Vink C
J Microbiol Methods; 2010 Sep; 82(3):214-22. PubMed ID: 20547188
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and Clinical Features of Community-Acquired Pneumonia Caused by Macrolide-Resistant
Choi JH; Seong GM; Ko Y; Kim YR; Kim C
Microb Drug Resist; 2019 May; 25(4):577-581. PubMed ID: 30484744
[No Abstract] [Full Text] [Related]
19. Molecular characterization and analysis of Mycoplasma pneumoniae among patients of all ages with community-acquired pneumonia during an epidemic in China.
Qu J; Chen S; Bao F; Gu L; Cao B
Int J Infect Dis; 2019 Jun; 83():26-31. PubMed ID: 30926541
[TBL] [Abstract][Full Text] [Related]
20. Genetic diversity and macrolide resistance of Mycoplasma pneumoniae isolates from two consecutive epidemics in Slovenia.
Kogoj R; Praprotnik M; Mrvič T; Korva M; Keše D
Eur J Clin Microbiol Infect Dis; 2018 Jan; 37(1):99-107. PubMed ID: 28948376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
